MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, UTMD had $2,088K increase in cash & cash equivalents over the period. $3,851K in free cash flow.

Cash Flow Overview

Change in Cash
$2,088K
Free Cash flow
$3,851K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net income
2,631 6,089
Depreciation
209 405
Amortization
545 1,048
Provision for (recovery of) losses on accounts receivable
402 -7
Amortization of right of use assets
15 26
Deferred income taxes
-281 -360
Stock-based compensation expense
94 168
Tax benefit attributable to exercise of stock options
0 0
Accounts receivable and other receivables
506 -409
Inventories
-101 -908
Prepaid expenses and other current assets
93 -145
Accounts payable
32 37
Accrued expenses
729 -1,531
Total adjustments
1,247 1,248
Net cash provided by operating activities
3,878 7,337
Property and equipment
27 235
Intangible assets
0 0
Property and equipment
0 0
Net cash used in investing activities
-27 -235
Proceeds from issuance of common stock - options
0 0
Common stock purchased and retired
653 6,708
Payment of dividends
988 2,018
Net cash used in financing activities
-1,641 -8,726
Effect of exchange rate changes on cash
-122 827
Net increase/(decrease) in cash and cash equivalents
2,088 -797
Cash and cash equivalents at beginning of period
82,976 -
Cash and cash equivalents at end of period
84,267 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

UTAH MEDICAL PRODUCTS INC (UTMD)

UTAH MEDICAL PRODUCTS INC (UTMD)